$WVE
Wave Life Sciences Ltd.

2016 Q3 Form 10-Q Financial Statement

#000119312516682053 Filed on August 15, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2016 Q2 2015 Q2
Revenue $392.0K $417.0K $126.0K
YoY Change 230.95%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.940M $3.650M $1.910M
YoY Change 37.76% 91.1%
% of Gross Profit
Research & Development $13.69M $8.401M $1.850M
YoY Change 541.93% 354.11%
% of Gross Profit
Depreciation & Amortization $190.0K $190.0K $90.00K
YoY Change -32.14% 111.11% -10.0%
% of Gross Profit
Operating Expenses $17.63M $12.06M $3.755M
YoY Change 253.21% 221.04% 190.63%
Operating Profit -$17.23M -$11.64M -$3.629M
YoY Change 245.35% 220.69%
Interest Expense $106.0K -$15.00K
YoY Change -806.67%
% of Operating Profit
Other Income/Expense, Net $80.00K $121.0K -$22.00K
YoY Change -41.61% -650.0%
Pretax Income -$17.15M -$11.52M -$3.651M
YoY Change 253.41% 215.45%
Income Tax $384.0K $48.00K $49.00K
% Of Pretax Income
Net Earnings -$17.54M -$11.57M -$3.700M
YoY Change 255.25% 212.57% 115.49%
Net Earnings / Revenue -4473.21% -2773.38% -2936.51%
Basic Earnings Per Share
Diluted Earnings Per Share -$748.0K -$509.5K -$176.8K
COMMON SHARES
Basic Shares Outstanding 23.44M shares 23.43M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q3 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $169.0M $181.8M $7.800M
YoY Change 156.06% 2230.77%
Cash & Equivalents $169.0M $181.8M $7.779M
Short-Term Investments
Other Short-Term Assets $600.0K $2.200M $800.0K
YoY Change -68.42% 175.0%
Inventory
Prepaid Expenses
Receivables $2.500M $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $172.1M $183.9M $8.600M
YoY Change 153.2% 2038.85%
LONG-TERM ASSETS
Property, Plant & Equipment $6.693M $5.093M $1.800M
YoY Change 242.53% 182.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.100M $1.300M $1.100M
YoY Change 0.0% 18.18%
Total Long-Term Assets $7.833M $6.397M $3.000M
YoY Change 160.32% 113.23%
TOTAL ASSETS
Total Short-Term Assets $172.1M $183.9M $8.600M
Total Long-Term Assets $7.833M $6.397M $3.000M
Total Assets $180.0M $190.3M $11.60M
YoY Change 153.5% 1540.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.825M $3.899M $2.100M
YoY Change 33.04% 85.67%
Accrued Expenses $4.800M $2.200M $200.0K
YoY Change 4700.0% 1000.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $11.43M $8.647M $2.500M
YoY Change 228.87% 245.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $522.0K $409.0K $0.00
YoY Change 1583.87%
Total Long-Term Liabilities $9.540M $7.539M $100.0K
YoY Change 7532.0% 7439.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.43M $8.647M $2.500M
Total Long-Term Liabilities $9.540M $7.539M $100.0K
Total Liabilities $20.97M $16.19M $2.600M
YoY Change 482.52% 522.54%
SHAREHOLDERS EQUITY
Retained Earnings -$72.02M -$54.49M
YoY Change 157.44%
Common Stock $215.5M $215.4M
YoY Change 860.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $151.1M $166.3M $9.000M
YoY Change
Total Liabilities & Shareholders Equity $180.0M $190.3M $11.60M
YoY Change 153.5% 1540.84%

Cashflow Statement

Concept 2016 Q3 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$17.54M -$11.57M -$3.700M
YoY Change 255.25% 212.57% 115.49%
Depreciation, Depletion And Amortization $190.0K $190.0K $90.00K
YoY Change -32.14% 111.11% -10.0%
Cash From Operating Activities -$11.83M $390.0K -$1.390M
YoY Change 315.09% -128.06% -30.5%
INVESTING ACTIVITIES
Capital Expenditures -$1.280M -$870.0K -$360.0K
YoY Change 150.98% 141.67% -30.77%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$990.0K
YoY Change -100.0% -419.35%
Cash From Investing Activities -$1.270M -$870.0K -$1.360M
YoY Change 149.02% -36.03% 547.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 190.0K 28.94M 20.00K
YoY Change -99.69% 144600.0% -99.64%
NET CHANGE
Cash From Operating Activities -11.83M 390.0K -1.390M
Cash From Investing Activities -1.270M -870.0K -1.360M
Cash From Financing Activities 190.0K 28.94M 20.00K
Net Change In Cash -12.91M 28.46M -2.730M
YoY Change -122.32% -1142.49% -180.06%
FREE CASH FLOW
Cash From Operating Activities -$11.83M $390.0K -$1.390M
Capital Expenditures -$1.280M -$870.0K -$360.0K
Free Cash Flow -$10.55M $1.260M -$1.030M
YoY Change 350.85% -222.33% -30.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23440423 shares
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7779000
CY2016Q2 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
25000
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23432923 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23432923 shares
CY2016Q2 us-gaap Assets
Assets
190338000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
183941000
CY2016Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181765000
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
215372000
CY2016Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7083000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3899000
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2500000
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5318000
CY2016Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2161000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
76000
CY2016Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
62000
CY2016Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
47000
CY2016Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
192000
CY2016Q2 us-gaap Other Assets
OtherAssets
57000
CY2016Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7539000
CY2016Q2 us-gaap Liabilities
Liabilities
16186000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
190338000
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
409000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8647000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5093000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
166278000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54488000
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2176000
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1055000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1048000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21551423 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21551423 shares
CY2015Q4 us-gaap Assets
Assets
165424000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
161384000
CY2015Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161220000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
185344000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2811000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3182000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
18000
CY2015Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
945000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
41000
CY2015Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
62000
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
78000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
192000
CY2015Q4 us-gaap Other Assets
OtherAssets
4000
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
241000
CY2015Q4 us-gaap Liabilities
Liabilities
4059000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
165424000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
163000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3818000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2789000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
153491000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35076000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
146000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1055000
us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
-474000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6731000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.82
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2492000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
114000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3789000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
178000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7187000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
99000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-15000
us-gaap Revenues
Revenues
152000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
28000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43000
us-gaap Operating Expenses
OperatingExpenses
7246000
us-gaap Net Income Loss
NetIncomeLoss
-7165000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7066000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1430000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-200000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1713000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7094000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
11646000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-355000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-152000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
99000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3011000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
378000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1055000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11631000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-3000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3457000
us-gaap Share Based Compensation
ShareBasedCompensation
2492000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8729072 shares
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
97000
wve Proceeds From Government Grant Reimbursements For Property And Equipment
ProceedsFromGovernmentGrantReimbursementsForPropertyAndEquipment
3000
wve Proceeds From Government Grant
ProceedsFromGovernmentGrant
112000
dei Entity Registrant Name
EntityRegistrantName
WAVE LIFE SCIENCES LTD.
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001631574
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
-72000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20545000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.88
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2136000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1039000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6870000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
337000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19377000
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
43000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
210000
us-gaap Revenues
Revenues
417000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
221000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000
us-gaap Operating Expenses
OperatingExpenses
20007000
us-gaap Net Income Loss
NetIncomeLoss
-19412000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19369000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1559000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
35000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1183000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2069000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19590000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-9000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
28922000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1208000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
9583000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6746000
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
1075000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1563000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30000000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000
dei Trading Symbol
TradingSymbol
WVE
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
254000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13137000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
28000
us-gaap Share Based Compensation
ShareBasedCompensation
2136000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22126562 shares
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
31000
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
646000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1905000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3694000
CY2015Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-15000
CY2015Q2 us-gaap Revenues
Revenues
126000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
3755000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-3700000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3651000
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3629000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1850000
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9223405 shares
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1270000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3654000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11541000
CY2016Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
106000
CY2016Q2 us-gaap Revenues
Revenues
417000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
121000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
12055000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-11565000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11517000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
24000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11638000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8401000
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22708022 shares

Files In Submission

Name View Source Status
0001193125-16-682053-index-headers.html Edgar Link pending
0001193125-16-682053-index.html Edgar Link pending
0001193125-16-682053.txt Edgar Link pending
0001193125-16-682053-xbrl.zip Edgar Link pending
d207833d10q.htm Edgar Link pending
d207833dex101.htm Edgar Link pending
d207833dex102.htm Edgar Link pending
d207833dex311.htm Edgar Link pending
d207833dex312.htm Edgar Link pending
d207833dex321.htm Edgar Link pending
d207833dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wve-20160630.xml Edgar Link completed
wve-20160630.xsd Edgar Link pending
wve-20160630_cal.xml Edgar Link unprocessable
wve-20160630_def.xml Edgar Link unprocessable
wve-20160630_lab.xml Edgar Link unprocessable
wve-20160630_pre.xml Edgar Link unprocessable